跳至主要内容
临床试验/NCT07787403
NCT07787403尚未招募不适用

A Personalized Interactive Patient Empowerment Artificial Intelligence Platform (PIPE-AI) Enhanced by DiabetesGPT in Prediabetes and Diabetes Patients in Primary Healthcare Settings

The Hong Kong Polytechnic University0 个研究点目标入组 50 人开始时间: 2026年8月29日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
主要终点
Change in Diabetes Self-Management Questionnaire total score from baseline to 3 months

研究概览

简要总结

This pilot randomized controlled trial evaluates the feasibility, effectiveness, and acceptance of the Personalized Interactive Patient Empowerment Artificial Intelligence Platform (PIPE-AI) enhanced by DiabetesGPT among adults with prediabetes or diabetes in Hong Kong primary healthcare settings. Participants will be randomized in a 1:1 ratio to an intervention group receiving PIPE-AI or to a waitlist control group receiving usual care during the first 3 months. Both groups will complete baseline and 3-month assessments, including patient-reported outcome measures, clinical outcomes, healthcare service utilization, and intermittent continuous glucose monitoring using Abbott FreeStyle Libre 2 Plus sensors.

详细描述

This study is a pilot randomized controlled trial designed to assess the feasibility, effectiveness, and acceptance of the PIPE-AI platform enhanced by DiabetesGPT before broader implementation in primary healthcare settings. The PIPE-AI platform integrates individualized risk assessments and a locally fine-tuned large language model, DiabetesGPT, to generate personalized health advice and patient empowerment support for people with prediabetes or diabetes.

Approximately 50 participants will be recruited and randomized in a 1:1 ratio to the intervention group or waitlist control group. Eligibility will be assessed by nurses and doctors in participating primary healthcare settings. After written informed consent, trained research assistants will conduct baseline assessments, including demographic and socioeconomic data, lifestyle behaviours, medical history, current medications, patient-reported outcome measures, and venous blood sampling for fasting glucose and HbA1c.

Randomization will be performed before recruitment by a statistician using R software. After baseline assessment, participants will receive an opaque letter containing their assigned group and follow-up instructions. Research assistants involved in subject recruitment and baseline assessment will be blinded to grouping to reduce measurement bias where operationally feasible.

Participants in the intervention group will install the PIPE-AI app and receive instructions on how to use it. An individualized patient empowerment programme will be provided during the 3-month follow-up period. App login frequency will be monitored on the server, and reminders may be sent by SMS, WhatsApp, or WeChat if a participant does not log in within one week after recruitment or stops logging in for more than one month.

Participants in the control group will follow a waitlist approach. During the first 3 months, they will receive usual care, including group-based patient empowerment programmes where available through the District Health Centre, general guidance from the Hong Kong Reference Framework for Diabetes Care for Adults in Primary Care Settings, or routine diabetes education and management services in their respective clinics. After the 3-month follow-up assessment, control group participants will be given access to the app.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

盲法说明

Participants and intervention staff cannot be blinded because the intervention group receives access to the PIPE-AI app. Participants will be randomized in a 1:1 ratio using sequentially numbered, opaque, sealed envelopes prepared before recruitment according to a pre-generated randomization list. After eligibility confirmation, written informed consent, and baseline assessment, the next available envelope will be opened according to the study SOP to reveal the assigned group and follow-up instructions. The envelope system is used for allocation concealment before assignment and to reduce selection bias.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 18 years or older.
  • Diagnosed with prediabetes or diabetes by their family doctors.
  • Able to understand Chinese.
  • Possess a mobile phone that can install the app developed for this project.

排除标准

  • Under legal guardianship.
  • Comorbid schizophrenia.
  • Intellectual disability.
  • Incompetent in giving consent.
  • Other significant cognitive disorders.

结局指标

主要结局

Change in Diabetes Self-Management Questionnaire total score from baseline to 3 months

时间窗: Baseline and 3-month follow-up

Diabetes self-management is assessed using the 16-item Diabetes Self-Management Questionnaire (DSMQ). After reverse scoring the applicable items, the DSMQ total score is transformed to a scale from 0 to 10 points; higher scores indicate better diabetes self-management. The reported outcome is the change score calculated as the 3-month total score minus the baseline total score, with a possible range from -10 to 10 points. A positive change indicates improvement.

Change in Michigan Diabetes Knowledge Test 2 general knowledge score from baseline to 3 months

时间窗: Baseline and 3-month follow-up

Diabetes knowledge is assessed using the 14-item general knowledge section of the Michigan Diabetes Knowledge Test 2 (DKT2). Each correct answer receives 1 point and an incorrect or missing answer receives 0 points. The general knowledge score ranges from 0 to 14 points; higher scores indicate greater diabetes knowledge. The reported outcome is the change score calculated as the 3-month score minus the baseline score, with a possible range from -14 to 14 points. A positive change indicates improvement.

次要结局

  • Change in HbA1c from baseline to 3 months(Baseline and 3-month follow-up)
  • Change in fasting glucose from baseline to 3 months(Baseline and 3-month follow-upFasting glucose will be measured by the study team or obtained through study procedures. The endpoint is the change in fasting glucose from baseline to the 3-month follow-up, using the same unit at both time points.)
  • User satisfaction with the PIPE-AI programme(3-month follow-up)

研究者

申办方类型
Other
责任方
Sponsor

相似试验